Historically the relationship between industry and the NHS has been a cautious one. Both sides have typically worked with only partially disclosed agendas, under a pervading fear of finding themselves on the wrong end of a win-lose negotiation. Things have...
‘Which drug rep is taking us out tonight?’ We have heard this phrase uttered at conferences since meetings began, but as Dylan said ‘those times they are a changing’ thanks to the Association of the British Pharmaceutical Industry (ABPI) and...
Background The auditory brainstem implant (ABI) has been developed from cochlear implant (CI) technology and is indicated for people who have anatomical abnormalities of the cochlea or dysfunction of the auditory nerve. The majority of people who have received an...
Rehabilitation of patients with profound hearing loss deemed unsuitable for cochlear implants is challenging. An auditory brainstem implant (ABI) is a viable option for these patients. This paper evaluates auditory and speech perception outcome measures following ABI in 10 postmeningitic...
Auditory brainstem implants were first used in adults with NF2. They have more recently become a technology option for children but what is the evidence to support this choice? This article discusses the evidence so far. Auditory brainstem implant is...
I was enormously grateful for the chance to articulate my personal thoughts on ‘the industry interaction with the ENT clinical community’. To set a context, the term ‘industry’ refers to medical technology manufacturers and suppliers, in addition to pharmaceutical companies....
In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...
In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...
Hearing rehabilitation is a key focus of the management of patients with vestibular schwannoma. But how do we rehabilitate hearing when the cochlear nerve has been damaged by tumour, irradiation, or resective surgery? Mathieu Trudel, Scott Rutherford and Simon Lloyd...
This article reviews the use of neuroprosthetic devices such as cochlear and auditory brainstem implants (ABI) to stimulate the auditory pathway, discussing the successes, limitations and advances in this area. Currently, neuroprosthetic devices deliver electrical impulses to the cochlear nerve...
10 August 2021
| B Nirmal Kumar (Prof), Gerard O’Donoghue, Sunil Narayan Dutt (Dr Prof)
|
ENT, Otology
Professor Shanmugam Kameswaran was born in 1923 and did his MBBS and MS at Madras Medical College, India, under PV Cherian who later became the Governor of Maharashtra, India. He worked as his assistant and left for the UK in...